325 related articles for article (PubMed ID: 4657429)
1. [Therapeutic trial of a new antidiabetic with vascular action: 1702 SE].
Jaillard J; Warembourg H
Lille Med; 1972 Oct; 17(9):Suppl 6:1332-6. PubMed ID: 4657429
[No Abstract] [Full Text] [Related]
2. A controlled clinical trial of a new oral hypoglycemic agent, glipizide (K 4024).
Lentini S; Bossini A; Pirola LC
Arzneimittelforschung; 1972 Jul; 22(7):1169-73. PubMed ID: 4678124
[No Abstract] [Full Text] [Related]
3. [Oral hypoglycemic therapy of diabetes mellitus].
Montenero P
Minerva Med; 1976 Jan; 67(3):208-15. PubMed ID: 1250219
[No Abstract] [Full Text] [Related]
4. [Clinical trial of glypizide].
Cañadell Vidal J
Rev Iber Endocrinol; 1974 Jan; 21(121):61-73. PubMed ID: 4826383
[No Abstract] [Full Text] [Related]
5. Pharmacological and clinical evaluation of the activity and tolerance of a new oral antidiabetic compound, glydiazinamide or K 4024.
Parodi FA
Isr J Med Sci; 1972 Jun; 8(6):888-92. PubMed ID: 5051831
[No Abstract] [Full Text] [Related]
6. [Glipizide, a new sulfonylurea in the treatment of diabetes mellitus].
Villaseñor A
Prensa Med Mex; 1973; 38(5):211-4. PubMed ID: 4782089
[No Abstract] [Full Text] [Related]
7. Controlling diabetes with diet and oral hypoglycemic agents.
Faludi G
Geriatrics; 1976 Oct; 31(10):67-70. PubMed ID: 964602
[No Abstract] [Full Text] [Related]
8. A new antidiabetic agent.
Gupta SD; Mukerjee AB
J Indian Med Assoc; 1974 Dec; 63(11):357-9. PubMed ID: 4282091
[No Abstract] [Full Text] [Related]
9. [Clinical study of a new sulfonylurea antidiabetic, glibornuride].
Vernet A; Fabre J; Zahnd G
Schweiz Rundsch Med Prax; 1972 Dec; 61(52):1599-607. PubMed ID: 4630563
[No Abstract] [Full Text] [Related]
10. [Clinical study of a new oral hypoglycemic agent: glypentide (UR-661)].
Calvet JM; Matarrodona M; Bordas R
Rev Iber Endocrinol; 1974; 21(124):347-62. PubMed ID: 4453782
[No Abstract] [Full Text] [Related]
11. [Long term efficacy and tolerance of antidiabetic treatments. New data].
Mirouze J
Nouv Presse Med; 1974 Jun; 3(24):1551-4. PubMed ID: 4211493
[No Abstract] [Full Text] [Related]
12. Clinical and metabolic observations with a new synthetic oral antidiabetic agent, glipizide.
D'Onofrio F; Pempinello R; Romis L
Arzneimittelforschung; 1972 Nov; 22(11):1879-81. PubMed ID: 4679059
[No Abstract] [Full Text] [Related]
13. [Therapy of diabetes in adults using Glibornurid. Results and clinical studies].
Schöffling K; Mehnert H; Ewald W; Haupt E; Wicklmayr M; Beyer J; Nemeth N
Dtsch Med Wochenschr; 1973 May; 98(18):915-9. PubMed ID: 4633717
[No Abstract] [Full Text] [Related]
14. [Oral antidiabetics].
Bäbler M
Schweiz Rundsch Med Prax; 1972 Feb; 61(8):242-6. PubMed ID: 4659095
[No Abstract] [Full Text] [Related]
15. [A new antidiabetic agent: glyclazide. A study of glycemic regulation].
Bour H; Denard Y; Plauchu M; Rathery M; Simonin R; Thervet F; Warembourg H
Nouv Presse Med; 1974 Feb; 3(5):249-51. PubMed ID: 4819946
[No Abstract] [Full Text] [Related]
16. [Evaluation of a new sulfonylurea, glipizide, in the treatment of diabetes mellitus].
Ninni M; Castelletta L
Minerva Med; 1973 Oct; 64(71):3725-31. PubMed ID: 4588364
[No Abstract] [Full Text] [Related]
17. [Results of a clinical test on the oral antidiabetic agent glibornuride (Ro 6-4563)].
Leubner H
Wien Med Wochenschr; 1973 Apr; 123(17):277-82. PubMed ID: 4574026
[No Abstract] [Full Text] [Related]
18. Effect of glipizide on a double-meal test in diabetic patients.
Vailati G; Pagani G; Montini M; Caputo G; Sacchetti G
Arzneimittelforschung; 1972 Nov; 22(11):1888-9. PubMed ID: 4679061
[No Abstract] [Full Text] [Related]
19. [Indications and limitations of oral hypoglycemic agents in the treatment of diabetes mellitus].
Guillon J; Charbonnel B
Cah Med; 1972 Nov; 13(14):999-1006. PubMed ID: 4646244
[No Abstract] [Full Text] [Related]
20. [Clinical evaluation of glypidizine, a new oral hypoglycemic agent].
Domingo Gutiérrez AJ; Fernández-Cruz A
Rev Iber Endocrinol; 1973; 20(117):289-303. PubMed ID: 4581992
[No Abstract] [Full Text] [Related]
[Next] [New Search]
